Timing for combined diuretic therapy in acute heart failure: should we continue waiting for the poor response?
DOI:
https://doi.org/10.58354/jvc.107E.2023.714Từ khóa:
acute heart failure, congestion, diuretic combinationTóm tắt
Decongestion is an important primary goal in acute heart failure treatment. Loop diuretics remain a fundamental role in congestion management and symptom improvement in patients with acute heart failure. Diuretic combination contributes to achieving better diuretic efficacy. However, the optimal timing for diuretic combination in clinical practice has not been distinctly recommended in current guidelines.
Tài liệu tham khảo
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368
Chioncel O, Mebazaa A, Maggioni AP, et al. Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry. Eur J Heart Fail. 2019;21(11):1338-1352. doi: 10.1002/ejhf.1492
Chioncel O, Mebazaa A, Harjola V, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry. Eur J Heart Fail. 2017;19(10):1242-1254. doi: 10.1002/ejhf.890
Boorsma EM, Ter Maaten JM, Damman K, et al. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol. 2020;17(10):641-655. doi: 10.1038/s41569-020-0379-7
Harjola V, Mullens W, Banaszewski M, et al. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017;19(7):821-836. doi: 10.1002/ejhf.872
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18). doi: 10.1161/CIR.0000000000001063
Mullens W, Damman K, Harjola V, et al. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(2):137-155. doi: 10.1002/ejhf.1369
Guidelines for the diagnosis and treatment of acute and chronic heart failure 2022 - Vietnam National Heart Association
Martens P, Nijst P, Mullens W. Current Approach to Decongestive Therapy in Acute Heart Failure. Curr Heart Fail Rep. 2015;12(6):367-378. doi:10.1007/s11897-015-0273-5
Ambrosy AP, Pang PS, Khan S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34(11):835-843. doi:10.1093/eurheartj/ehs444
Damman K, Beusekamp JC, Boorsma EM, et al. Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF). Eur J Heart Fail. 2020;22(4):713-722. doi:10.1002/ejhf.1713
Cooper LB, Lippmann SJ, DiBello JR, et al. The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure. Am J Cardiol. 2019;124(4):545-553. doi:10.1016/j.amjcard.2019.05.030
Masson R, Ambrosy AP, Kheder K, et al. A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF). J Cardiovasc Transl Res. 2020;13(4):540-548. doi:10.1007/s12265-020-09954-x
Lala A, McNulty SE, Mentz RJ, et al. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail. 2015;8(4):741-748. doi:10.1161/CIRCHEARTFAILURE.114.001957
Pandhi P, Ter Maaten JM, Emmens JE, et al. Clinical value of pre‐discharge bio‐adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. Eur J Heart Fail. 2020;22(4):683-691. doi:10.1002/ejhf.1693
Brater DC. Pharmacokinetics of loop diuretics in congestive heart failure. Heart. 1994;72(2 Suppl):S40-S43. doi:10.1136/hrt.72.2_Suppl.S40
Mebazaa A, Tolppanen H, Mueller C, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med. 2016;42(2):147-163. doi:10.1007/s00134-015-4041-5
Mentz RJ, Kjeldsen K, Rossi GP, et al. Decongestion in acute heart failure. Eur J Heart Fail. 2014;16(5):471-482. doi:10.1002/ejhf.74
Ter Maaten JM, Dunning AM, Valente MAE, et al. Diuretic response in acute heart failure—an analysis from ASCEND-HF. Am Heart J. 2015;170(2):313-321.e4. doi:10.1016/j.ahj.2015.05.003
Takagi K, Kimmoun A, Sato N, et al. Management of Acute Heart Failure during an Early Phase. Int J Heart Fail. 2020;2(2):91. doi:10.36628/ijhf.2019.0014
Cox ZL, Collins SP, Aaron M, et al. Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial. Am Heart J. 2021;232:116-124. doi:10.1016/j.ahj.2020.10.071
Channer KS, McLean KA, Lawson-Matthew P, et al. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Heart. 1994;71(2):146-150. doi:10.1136/hrt.71.2.146
Mouallem M, Brif I, Mayan H, et al. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. Int J Cardiol. 1995;50(2):89-94. doi:10.1016/0167-5273(95)93677-K
Dormans TPJ, Gerlag PGG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J. 1996;17(12):1867-1874. doi:10.1093/oxfordjournals.eurheartj.a014805
Piardi DS, Butzke M, Mazzuca ACM, et al. Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial. Sci Rep. 2021;11(1):16474. doi:10.1038/s41598-021-96002-6
Ng TMH, Konopka E, Hyderi AF, et al. Comparison of Bumetanide- and Metolazone-Based Diuretic Regimens to Furosemide in Acute Heart Failure. J Cardiovasc Pharmacol Ther. 2013;18(4):345-353. doi:10.1177/1074248413482755
Trullàs JC, Morales-Rull JL, Casado J, et al. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J. 2023;44(5):411-421. doi:10.1093/eurheartj/ehac689
Mullens W, Dauw J, Martens P, et al. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. N Engl J Med. 2022;387(13):1185-1195. doi:10.1056/NEJMoa2203094
